CG Oncology, Inc.CG Oncology, Inc.CG Oncology, Inc.

CG Oncology, Inc.

No trades
See on Supercharts

CGON fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

CG Oncology, Inc. is a clinical biopharmaceutical company, which engages in the development and commercialization of bladder-sparing therapeutic for patients afflicted with bladder cancer. It offers cretostimogene, a product initially in clinical development for the treatment of patients with Non-Muscle Invasive Bladder Cancer (NMIBC). The company was founded by Alex Yeung and Paul A. DeRidder on September 24, 2010 and is headquartered in Irvine, CA.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
CGON has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company